البحث | MTSocial

Harshasharma Harshasharma أضاف وظيفة جديدة أخرى
2025-11-10 10:28:41 -

Trastuzumab Emtansine Market: A Precision Oncology Game-Changer on the Rise
The global trastuzumab emtansine market size was valued at USD 2.47 billion in 2024 and is expected to reach USD 4.78 billion by 2032, at a CAGR of 8.62% during the forecast period Introduction Trastuzumab emtansine is an antibody-drug conjugate (ADC) designed to deliver the cytotoxic agent DM1 (a maytansine derivative) to HER2-positive cancer cells via the...

0 التعليقات 0 المشاركات 456 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Harshasharma Harshasharma أضاف وظيفة جديدة Networking
2025-12-01 07:43:05 -

Trastuzumab Emtansine Market: A Precision Oncology Game-Changer on the Rise
Targeted drug conjugates are reshaping cancer therapy, and trastuzumab emtansine (T-DM1, Kadcyla) stands at the forefront by combining antibody specificity with cytotoxic potency.This market analysis delves into growing demand, regulatory shifts, emerging indications, and competitive dynamics in the trastuzumab emtansine landscape. Introduction Trastuzumab emtansine is an antibody-drug...

0 التعليقات 0 المشاركات 235 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Harshasharma Harshasharma أضاف وظيفة جديدة أخرى
2025-10-30 08:51:15 -

Trastuzumab Emtansine Market: A Precision Oncology Game-Changer on the Rise
The global trastuzumab emtansine market size was valued at USD 2.47 billion in 2024 and is expected to reach USD 4.78 billion by 2032, at a CAGR of 8.62% during the forecast period Introduction Trastuzumab emtansine is an antibody-drug conjugate (ADC) designed to deliver the cytotoxic agent DM1 (a maytansine derivative) to HER2-positive cancer cells via the...

0 التعليقات 0 المشاركات 596 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
Harshasharma Harshasharma أضاف وظيفة جديدة أخرى
2025-10-15 09:09:41 -

Trastuzumab Emtansine Market: A Precision Oncology Game-Changer on the Rise
Targeted drug conjugates are reshaping cancer therapy, and trastuzumab emtansine (T-DM1, Kadcyla) stands at the forefront by combining antibody specificity with cytotoxic potency.This market analysis delves into growing demand, regulatory shifts, emerging indications, and competitive dynamics in the trastuzumab emtansine landscape. Introduction Trastuzumab emtansine is an antibody-drug...

0 التعليقات 0 المشاركات 680 مشاهدة 0 معاينة

الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!